Association between the dual use of electronic and conventional cigarettes and NAFLD status in Korean men

Abstract

Introduction This study investigated the association between smoking types, including dual use (usage of both combustible cigarettes and e-cigarettes), and non-alcoholic fatty liver disease (NAFLD) status in Korean men. Methods Data from the 7th and 8th Korea National Health and Nutrition Examination Survey (KNHANES) 2016–2020 were used. The presence of NAFLD was defined by the respective cut-off values for the Hepatic Steatosis Index (HSI), NAFLD Ridge Score (NRS), and Korea National Health and Nutrition Examination Survey NAFLD score (KNS). Multivariate logistic regression analyses were used to determine the associations between smoking types and NAFLD as determined by HSI, NRS, and KNS. Results After adjustment for confounders, an independent association was observed between dual use and NAFLD (HSI: AOR=1.47; 95% CI: 1.08–1.99, p=0.014; NRS: AOR=2.21; 95% CI: 1.70–2.86, p=0.000; KNS: AOR=1.35; 95% CI: 1.01– 1.81, p=0.045). Cigarette only smokers also had significantly higher odds of NAFLD compared to never smokers for all of the NAFLD indices (HSI: AOR=1.22; 95% CI: 1.05–1.42, p=0.008; NRS: AOR=2.13; 95% CI: 1.87–2.42, p=0.000; KNS: AOR=1.33; 95% CI: 1.14–1.55, p=0.000). In subgroup analyses, no significant interaction effects were found for age, BMI, alcohol consumption, income, physical activity, and the diagnosis of T2DM. Moreover, cigarette only smokers and dual users differed significantly in terms of log-transformed urine cotinine and packyears. The relationship between smoking type and pack-years was attenuated after stratification by age. Conclusions This study shows that the dual use of e-cigarettes and combustible cigarettes is associated with NAFLD. Age differences may explain why dual users, with a greater proportion of young people, appear to have fewer pack-years than cigarette only smokers. Further research should be conducted to investigate the adverse effects of dual use on hepatic steatosis.

Keywords

• smoking
• nonalcoholic fatty liver disease
• dual use
• electronic inhalable products
• scoring systems